Meca-Lallana JE, Martinez Yelamos S, Eichau S, Llaneza MA, Martin Martinez J, Pena Martinez J, Meca Lallana V, Alonso Torres AM, Moral Torres E, Rio J, Calles C, Ares Luque A, Ramio-Torrenta L, Marzo Sola ME, Prieto JM, Martinez Gines ML, Arroyo R, Otano Martinez MA, Brieva Ruiz L, Gomez Gutierrez M, Rodriguez-Antiguedad Zarranz A, Sanchez-Seco VG, Costa-Frossard L, Hernandez Perez MA, Landete Pascual L, Gonzalez Platas M, Oreja-Guevara C. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023. Neurologia (Engl Ed). 2024 Mar;39(2):196-208. doi: 10.1016/j.nrleng.2024.01.003. Epub 2024 Jan 16. PubMed PMID: 38237804.
AÑO: 2024; IF: 2.9
|
Millan-Pascual J, Valero-Lopez G, Iniesta-Martinez F, Hellin-Gil MF, Jimenez-Veiga J, Lopez-Tovar IA, Morales-Ortiz A, Meca-Lallana JE. Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurol Ther. 2024 Feb;13(1):153-164. doi: 10.1007/s40120-023-00572-8. Epub 2023 Dec 14. PubMed PMID: 38097868; PubMed Central PMCID: PMC10787726.
AÑO: 2024; IF: 3.9
|
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Costa-Frossard L, Eichau S, Garcia-Dominguez JM, Hernandez MA, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Prieto JM, Ramio-Torrenta L, Tellez N, Romero-Pinel L, Vilaseca A, Rodriguez-Antiguedad A. [XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)]. Rev Neurol. 2024 Jul 1;79(1):21-29. doi: 10.33588/rn.7901.2024170. Spanish. PubMed PMID: 38934946; PubMed Central PMCID: PMC11468034.
AÑO: 2024; IF: 0.8
|
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Costa-Frossard L, Eichau S, Garcia-Dominguez JM, Hernandez MA, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Prieto JM, Ramio-Torrenta L, Tellez N, Romero-Pinel L, Vilaseca A, Rodriguez-Antiguedad A. [XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (II)]. Rev Neurol. 2024 Jul 16;79(2):51-66. doi: 10.33588/rn.7902.2024174. Spanish. PubMed PMID: 38976584; PubMed Central PMCID: PMC11469095.
AÑO: 2024; IF: 0.8
|
Oreja-Guevara C, Meca-Lallana JE, Diaz-Diaz J, Ara JR, Hernandez Perez MA, Gracia Gil J, Alonso Torres AM, Pilo de la Fuente B, Ramio-Torrenta L, Eichau Madueno S, Gascon-Gimenez F, Casanova B, Martinez-Yelamos S, Aguado Valcarcel M, Martinez Gines ML, El Berdei Montero Y, Lopez Real AM, Gonzalez-Quintanilla V, De Torres L, Martinez-Rodriguez JE, Costa-Frossard L, Garces Redondo M, Labiano Fontcuberta A, Castellanos-Pinedo F, Garcia Merino JA, Munoz Fernandez C, Castillo-Trivino T, Meca-Lallana V, Pena Martinez J, Rodriguez-Antiguedad A, Prieto Gonzalez JM, Aguera Morales E, Perez Molina I, Solar Sanchez DM, Herrera Varo N, Romero Sevilla R, Gomez Vicente L, Rio J. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study. Mult Scler Relat Disord. 2024 Oct;90:105787. doi: 10.1016/j.msard.2024.105787. Epub 2024 Aug 2. PubMed PMID: 39142050.
AÑO: 2024; IF: 2.9
|